ACY-738   Click here for help

GtoPdb Ligand ID: 11120

Synonyms: example 73 [WO2012068109A2]
Compound class: Synthetic organic
Comment: ACY-738 is an orally-bioavailable histone deacetylase (HDAC) inhibitor [1-2]. It has some selectivity for HDAC6.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 3
Rotatable bonds 5
Topological polar surface area 87.14
Molecular weight 270.11
XLogP 1.08
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES ONC(=O)c1cnc(nc1)NC1(CC1)c1ccccc1
Isomeric SMILES ONC(=O)c1cnc(nc1)NC1(CC1)c1ccccc1
InChI InChI=1S/C14H14N4O2/c19-12(18-20)10-8-15-13(16-9-10)17-14(6-7-14)11-4-2-1-3-5-11/h1-5,8-9,20H,6-7H2,(H,18,19)(H,15,16,17)
InChI Key LIIWIMDSZVNYHY-UHFFFAOYSA-N
References
1. Cao Y, Ding Y, Liu Y, Mazitschek R, Van Duzer JH, Yu N. (2012)
Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof.
Patent number: WO2012068109A2. Assignee: Acetylon Pharmaceuticals. Priority date: 16/11/2010. Publication date: 24/05/2012.
2. Jochems J, Boulden J, Lee BG, Blendy JA, Jarpe M, Mazitschek R, Van Duzer JH, Jones S, Berton O. (2014)
Antidepressant-like properties of novel HDAC6-selective inhibitors with improved brain bioavailability.
Neuropsychopharmacology, 39 (2): 389-400. [PMID:23954848]
3. LoPresti P. (2019)
The Selective HDAC6 Inhibitor ACY-738 Impacts Memory and Disease Regulation in an Animal Model of Multiple Sclerosis.
Front Neurol, 10: 519. [PMID:31316445]